Bio-Rad to Participate at the 37th Annual J.P. Morgan Healthcare Conference on January 8
January 02 2019 - 6:10PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
of life science research and clinical diagnostic products, today
announced that Norman Schwartz, President and CEO, and Christine
Tsingos, Executive Vice President and CFO, will participate in the
37th Annual J.P. Morgan Healthcare Conference on Tuesday, January
8, at 1:30 PM (Pacific Time), at the Westin St. Francis Hotel, San
Francisco, California.
A link to the live webcast of the presentation will be available
in the Investor Relations area of our website at
www.bio-rad.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global
leader in developing, manufacturing, and marketing a broad range of
innovative products and solutions for the life science research and
clinical diagnostic markets. With a focus on quality and customer
service for over 65 years, our products advance the discovery
process and improve healthcare. Our customers are university and
research institutions, hospitals, public health and commercial
laboratories, biotechnology, pharmaceutical, as well as applied
research laboratories that include food safety and environmental
quality testing. Founded in 1952, Bio-Rad is based in Hercules,
California, and has a global network of operations with more than
8,000 employees worldwide. Bio-Rad had revenues exceeding $2.1
billion in 2017. For more information, please visit
www.bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190102005649/en/
Bio-Rad Laboratories, Inc.Tina Cuccia, Corporate
Communications510-724-7000tina_cuccia@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Sep 2023 to Sep 2024